Sleep Aids (Pharmacies) - Central & Western Europe

  • Central & Western Europe
  • Revenue in the Sleep Aids market is projected to reach US$0.85bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 2.00%, resulting in a market volume of US$0.92bn by 2028.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.53 are generated in 2024.

Key regions: South Korea, Japan, Canada, France, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Central & Western Europe is experiencing significant growth due to changing customer preferences and trends in the market.

Customer preferences:
Customers in Central & Western Europe are increasingly seeking sleep aids to help them manage sleep disorders and improve the quality of their sleep. Sleep disorders such as insomnia and sleep apnea are becoming more prevalent in the region, leading to a higher demand for sleep aids. Additionally, the fast-paced and stressful lifestyles of individuals in Central & Western Europe are contributing to sleep problems, further driving the demand for sleep aids.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in Central & Western Europe is the growing popularity of natural sleep aids. Customers are becoming more conscious of the potential side effects of synthetic sleep aids and are opting for natural alternatives. Natural sleep aids, such as herbal supplements and aromatherapy products, are gaining traction in the market due to their perceived safety and effectiveness. Another trend in the market is the increasing availability of sleep aids in pharmacies. Pharmacies are expanding their product offerings to include a wide range of sleep aids, catering to the growing demand from customers. This trend is driven by the convenience and accessibility of pharmacies, making it easier for customers to purchase sleep aids.

Local special circumstances:
Each country in Central & Western Europe has its own unique set of circumstances that impact the Sleep Aids (Pharmacies) market. For example, in Germany, there is a strong emphasis on natural and holistic remedies, which has led to a higher demand for natural sleep aids. In France, there is a cultural preference for homeopathic remedies, which has influenced the types of sleep aids available in the market.

Underlying macroeconomic factors:
The Sleep Aids (Pharmacies) market in Central & Western Europe is also influenced by underlying macroeconomic factors. The region has a high disposable income, allowing customers to afford sleep aids and other healthcare products. Additionally, the aging population in Central & Western Europe is contributing to the growth of the market, as older individuals are more likely to experience sleep problems and seek sleep aids. In conclusion, the Sleep Aids (Pharmacies) market in Central & Western Europe is experiencing growth due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for sleep aids, particularly natural alternatives, is driving the expansion of the market. Pharmacies are playing a key role in meeting this demand by offering a wide range of sleep aids. As the region continues to face sleep disorders and high levels of stress, the Sleep Aids (Pharmacies) market in Central & Western Europe is expected to continue growing in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)